Itamar Medical Ltd (ITMMF) 0.2850 $ITMMF
Respiratory Care Equipment and Supplies 2014-2020 - Global Strategic Business Report 2015
M2 - Thu Oct 15, 3:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qgh36t/respiratory_care) has announced the addition of the "Respiratory Care Equipment and Supplies - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, The Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. This report analyzes the worldwide markets for Respiratory Care Equipment and Supplies in US$ Thousand by the following Product Segments: Spirometers, Other Pulmonary Function Testing (PFT) Equipment, Sleep Apnea Diagnostic Devices, Ventilators, Humidifiers, Nebulizers, PAP (positive airway pressure) Devices, Oxygen Equipment, Manual Resuscitators, and Masks, Circuits & Disposables. The report profiles 158 companies including many key and niche players such as - Allied Healthcare Products, Inc. (USA) - Bio-Med Devices, Inc. (USA) - CareFusion Corp. (USA) - CAIRE, Inc. (USA) - Compumedics Ltd. (Australia) - Dr?ger Medical AG & Co. KGaA (Germany) - DeVilbiss Healthcare LLC (USA) - Fisher & Paykel Healthcare Corp. Limited (New Zealand) - GE Healthcare (UK) - Getinge Group (Sweden) - MAQUET GmbH & Co. KG (Germany) - Hamilton Medical AG (Switzerland) - Invacare Corporation (USA) - Itamar Medical Ltd. (Israel) - Medtronic PLC (Ireland) - nSpire Health, Inc. (USA) - PARI Medical Holding GmbH (Germany) - Philips Healthcare (The Netherlands) - ResMed (USA) - VORTRAN Medical Technology (USA) - Weinmann Ger?te f?r Medizin GmbH CCo. KG (Germany) Key Topics Covered: 1. Industry Overview 2. Competition In The Respiratory Care Market 3. Market Trends By Product Segment 4. Home Healthcare Market - A Broad Spectrum 5. Product Overview 6. Respiratory Therapy Equipment - A Review 7. Pap Devices - The Largest Market Segment In Respiratory Care 8. Ventilators For Respiratory Care 9. Review Of Select Disease Conditions Requiring Respiratory Care 10. Product Introductions, Innovations & Approvals 11. Recent Industry Activity 12. Focus On Select Global Players 13. Global Market Perspective Total Companies Profiled: 158 (including Divisions/Subsidiaries - 174) - The United States (84) - Canada (4) - Japan (9) - Europe (55) - - France (2) - - Germany (21) - - The United Kingdom (9) - - Italy (6) - - Spain (1) - - Rest of Europe (16) - Asia-Pacific (Excluding Japan) (16) - Latin America (1) - Middle East (5) For more information visit http://www.researchandmarkets.com/research/qg...atory_care
MDT: 82.94 (-0.05), IVC: 11.24 (+0.25), AHPI: 0.60 (-0.02)
Itamar Medical Offers a Total Sleep Apnea Management Solution to Cardiologists
PR Newswire - Wed May 13, 8:00AM CDT
For the first time, the company will manage and coordinate all stages of diagnosis and treatment for hospitals
European Sleep Apnea Devices Market, by Segment, and Sleep Apnea Therapeutic Devices - Forecast to 2019
M2 - Wed May 06, 6:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bjqw72/european_sleep) has announced the addition of the "European Sleep Apnea Devices Market, by Segment (Sleep Apnea Diagnostic Devices (Home Sleep Testing, Respiratory Polygraphs, Actigraphy Systems) and Sleep Apnea Therapeutic Devices (Pap Devices, Oxygen Devices, Airway Clearance Systems)-Forecast to 2019" report to their offering. The European sleep apnea devices market is projected to grow at a CAGR of 16.0% from 2014 to 2019 Germany holds the largest share of the European sleep apnea devices market. This large share of the German segment is attributed to the various driving forces, such as the increasing prevalence of sleep disorders in this region, increasing awareness level among patients and caregivers, rising number of cases of cardiovascular disorders, and the availability of technologically advanced diagnostic and therapeutic devices. However, the inadequate reimbursement coverage and patient compliance are perceived to hinder the growth of this market in the coming years. The high costs associated with the diagnosis and treatment of sleep apnea also restrains the growth of devices market in this region. The research report classifies the European sleep apnea devices market on the basis of segment into sleep apnea therapeutic devices and sleep apnea diagnostic devices. The sleep apnea therapeutic devices is further segmented based on types into home sleep testing/portable monitoring, sleep labs, respiratory polygraphs, two channel screening devices, single channel screening devices, and actigraphy systems. Similarly, the sleep apnea therapeutic devices market is segmented based on the types into Positive Airway Pressure (PAP) devices, masks, adaptive servo-ventilation, airway clearance systems, oxygen devices, and oral appliances. The PAP devices segment is the largest contributor in the therapeutic devices market. Moreover, the therapeutic devices segment is the largest contributor to the overall European sleep apnea devices market, having accounted for a share of 58.1% in 2014. Further, the European sleep apnea devices market is segmented based on the major countries of the region, such as Germany, France, the U.K., Italy, Spain, and the Rest of Europe (RoE). Germany is the largest market for sleep apnea devices in Europe. It accounted for a share of 27.9% of the European sleep apnea devices market in 2014. The major factors contributing to its dominance are the increasing prevalence of sleep disorders, rising awareness among patients and caregivers, and availability of advanced diagnosis and therapy options. France is the second-largest market in Europe and is projected to grow at a CAGR of 16.6% from 2014 to 2019. The U.K. houses the fastest-growing segment of the European sleep apnea devices market, and is projected to grow at the fastest CAGR from 2014 to 2019. The rising research & development activities pertaining to sleep disorders, rising obesity rates, and increasing awareness levels among patients and caregivers, are some of the factors expected to drive the growth of the European sleep apnea devices market in the coming years. Companies Mentioned - Ambulatory Monitoring, Inc. - BMC Medical Co., Ltd. - Carefusion Corporation - Compumedics Limited - Devilbiss Healthcare - Fisher and Paykel Healthcare Ltd. - Itamar Medical, Ltd. - Natus Medical, Inc. - Nihon Kohden - Nonin Medical - Philips Respironics (Subsidiary of Philips Healthcare Ltd.) - Resmed, Inc. - Somnomedics Gmbh - Weinmann Medical Devices Gmbh & Co. Kg For more information visit http://www.researchandmarkets.com/research/bj...pean_sleep
BABY: 34.16 (+0.19)
Sleep Apnea Devices Market by Segments (Sleep Apnea Therapeutic Devices, Sleep Apnea Diagnostic Devices) - Global Forecast to 2019
M2 - Thu Apr 23, 9:08AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lnxd5m/sleep_apnea) has announced the addition of the "Sleep Apnea Devices Market by Segments (Sleep Apnea Therapeutic Devices, Sleep Apnea Diagnostic Devices) - Global Forecast to 2019" report to their offering. The global sleep apnea devices market is expected to grow at a CAGR of 16.6% during the forecast period of 2014 to 2019. North America is the largest market in the global sleep apnea devices market, with a market share of 51.8% as of 2013, followed by Europe and Asia. The largest share of the North American segment is associated with various driving forces, such as the increasing patient pool of sleep apnea in this region, increasing awareness level among patients and caregivers, and the availability of technologically advanced diagnostic and therapeutic devices. It is estimated that approximately 4% of men and 2% of women suffer from Obstructive Sleep Apnea (OSA) globally. Also, the rising prevalence of comorbidities (such as drug-resistant hypertension, congestive heart failure, Type 2 diabetes, and stroke, among others) ensures that the global sleep apnea patient pool will grow in the coming years. However, the inadequate reimbursement coverage and patient compliance are perceived to hinder the growth of this market during the forecast period, 2014 to 2019. In this report, the global sleep apnea devices market is broadly classified on the basis of segments, namely sleep apnea therapeutic devices and sleep apnea diagnostic devices. The sleep apnea therapeutic devices is further segmented based on types, into home sleep testing/portable monitoring, sleep labs, respiratory polygraphs, two-channel screening devices, single channel screening devices, and actigraphy systems. Similarly, the sleep apnea therapeutic devices market is segmented based on types, into Positive Airway Pressure (PAP) devices, masks, adaptive servo-ventilation, airway clearance systems, oxygen devices, and oral appliances. PAP devices segment is the highest contributor in the therapeutic devices market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Global Sleep Apnea Devices Market, By Type 6 Global Sleep Apnea Market, By Geography 7 Global Sleep Apnea Devices Market: Competitive Landscape 8 Sleep Apnea Devices Market, By Company - Advanced Brain Monitoring,Inc., - Ambulatory Monitoring, Inc. - Bmc Medical Co., Ltd. - Cadwell Laboratories, Inc. - Carefusion Corporation - Clevemed - Compumedics Limited - Fisher And Paykel Healthcare Ltd. - Itamar Medical, Ltd. - Natus Medical, Inc. - Nihon Kohden - Nonin Medical - Novasom - Philips Respironics (Subsidiary Of Philips Healthcare Ltd.) - Resmed, Inc. - Weinmann Medical Devices Gmbh & Co. Kg For more information visit http://www.researchandmarkets.com/research/ln...leep_apnea
BABY: 34.16 (+0.19)
New Agreement Puts Itamar Medical Inc. and Arterial Health International on Track to Offer Greater Access to Innovative Cardiovascular Testing in the United States
PR Newswire - Mon Apr 20, 7:45AM CDT
Itamar Medical Inc., a subsidiary of Itamar Medical Ltd. (TASE: ITMR) and Arterial Health International LLC (AHI) announced today they have signed last month a representation agreement.
Micro Market Monitor: North American Sleep Apnea Devices
M2 - Thu Dec 18, 6:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/dnzfqg/micro_market) has announced the addition of the "Micro Market Monitor: North American Sleep Apnea Devices" report to their offering. The North American sleep apnea devices market is estimated to grow at a CAGR of 15.9% from 2014 to 2019. In 2013, the U.S. held the largest share in the North American sleep apnea devices market with 92.2%, followed by Canada. This market holds high growth potential in the future due to a number of forces favoring this market. These include the continuously growing base of sleep apnea patients, increasing awareness of sleep apnea and available diagnostic/therapeutic options, emerging popularity of oral appliances, and technological advancement. About 4% of men and 2% of women suffer from obstructive sleep apnea (OSA), globally. Due to rising obesity rates, the association of comorbidities such as drug-resistant hypertension, congestive heart failure, Type 2 diabetes, and stroke, the global sleep apnea patient pool is likely to grow in the years to come. However, dearth of reimbursement/insurance coverage and patient compliance seem to be hindering the growth of this market. In this report, the North American sleep apnea devices market is broadly classified into sleep apnea diagnostic devices and sleep apnea therapeutic devices. On the basis of products, the sleep apnea diagnostic devices market is further divided into home sleep testing/portable monitoring, traditional diagnostic (fixed PSG/in-lab PSG devices), respiratory polygraphs, two channel screening devices, single channel screening devices, and actigraphy systems. Key Topics Covered: 1 Executive Summary 2 Introduction 3 Market Overview 4 North American Sleep Apnea Devices Market, By Segment/Geography 5 Competitive Landscape 6 Company Profiles Companies Mentioned: - Advanced Brain Monitoring - Ambulatory Monitoring - Bmc Medical - Cadwell Laboratories - Carefusion Corporation - Clevemed - Compumedics - Fisher And Paykel Healthcare - Itamar Medical - Natus Medical - Nihon Kohden - Novasom - Philips Healthcare - Resmed - Weinmann Medical Devices Gmbh & Co For more information visit http://www.researchandmarkets.com/research/dn...cro_market
BABY: 34.16 (+0.19)
Sleep Apnea Diagnostic and Therapeutic Devices - 2014 Global Strategic Business Report
M2 - Thu Oct 30, 6:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qbnnd7/sleep_apnea) has announced the addition of the "Sleep Apnea Diagnostic and Therapeutic Devices - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 71 companies including many key and niche players such as: - Cadwell Laboratories, Inc. - CareFusion Corporation - Cleveland Medical Devices, Inc. - Compumedics Ltd. - DeVilbiss Healthcare - Global Medical Holdings LLC - Fisher & Paykel Healthcare Limited - GE Healthcare - Itamar Medical Ltd. - Invacare Corporation - Natus Medical Inc. - Embla Systems, Inc. - Grass Technologies - Philips Healthcare - ResMed Inc. - Teleflex Medical - Weinmann Ger?te f?r Medizin GmbH CCo. KG Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Market Overview 2. Market Trends And Dynamics 3. Sleep Apnea - A Synopsis 4. Sleep Apnea Diagnostic And Therapeutic Devices 5. Research Findings In Recent Past 6. Product Launches/Introductions 7. Recent Industry Activity 8. Focus On Select Players 9. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Middle East And Africa IV. Competitive Landscape Total Companies Profiled: 71 (including Divisions/Subsidiaries - 76) - The United States (48) - Canada (4) - Japan (1) - Europe (12) - - Germany (3) - - The United Kingdom (2) - - Italy (2) - - Spain (2) - - Rest of Europe (3) - Asia-Pacific (Excluding Japan) (
- Middle East (3) For more information visit http://www.researchandmarkets.com/research/qb...leep_apnea
BABY: 34.16 (+0.19), IVC: 11.24 (+0.25), RMD: 59.54 (-0.01)
Respiratory Care Equipment and Supplies - 2014 Global Strategic Business Report
M2 - Tue Oct 28, 4:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9qjvss/respiratory_care) has announced the addition of the "Respiratory Care Equipment and Supplies - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. This report analyzes the worldwide markets for Respiratory Care Equipment and Supplies in US$ Thousands by the following Product Segments: - Spirometers - Other Pulmonary Function Testing (PFT) Equipment - Sleep Apnea Diagnostic Devices - Ventilators - Humidifiers - Nebulizers - PAP (positive airway pressure) - Devices - Oxygen Equipment - Manual Resuscitators - Masks - Circuits & Disposables The report profiles 148 companies including many key and niche players such as: - AirSep Corporation - Allied Healthcare Products, Inc. - CareFusion Corporation - Compumedics Limited - Covidien Ltd. - Dr?ger Medical AG & Co. KGaA - DeVilbiss Healthcare - Fisher & Paykel Healthcare Corporation Limited - GE Healthcare - Getinge Group - MAQUET GmbH & Co. KG - Hamilton Medical AG - Invacare Corporation - Itamar Medical Ltd. - nSpire Health, Inc. - Philips Healthcare - ResMed - VORTRAN Medical Technology - Weinmann Ger?te f?r Medizin GmbH CCo. KG Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Respiratory Care Industry Classification 3. Competition In The Respiratory Care Market 4. Market Trends And Growth Drivers By Segment 5. Respiratory Diagnostics Equipment - A Review 6. Respiratory Therapy Equipment - A Review 7. Review Of Select Disease Conditions Requiring Respiratory Care 8. Pap Devices - The Largest Market Segment In Respiratory Care 9. Home Healthcare Market - A Broad Spectrum 10. Ventilators For Respiratory Care 11. Product Introductions/Innovations 12. Recent Industry Activity 13. Focus On Select Global Players 14. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. The Middle East 7. Latin America IV. Competitive Landscape Total Companies Profiled: 148 (including Divisions/Subsidiaries - 174) - The United States (78) - Canada (4) - Japan (9) - Europe (62) - - France (4) - - Germany (24) - - The United Kingdom (9) - - Italy (7) - - Spain (2) - - Rest of Europe (16) - Asia-Pacific (Excluding Japan) (15) - Latin America (1) - Middle East (5) For more information visit http://www.researchandmarkets.com/research/9q...atory_care
IVC: 11.24 (+0.25), COV: 106.71 (-1.36), AHPI: 0.60 (-0.02)
Galmed Pharmaceuticals and Itamar Medical to Collaborate on Assessing Aramchol's Effect on Endothelial Function
PR Newswire - Mon Sep 29, 8:13AM CDT
Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed"
, a clinical-stage biopharmaceutical company focused on the development and commercialization of a once-daily, oral medication for the treatment of liver diseases and cholesterol gallstones, announced today that it purchased 60 EndoPAT(TM) devices and accessories from Itamar Medical Ltd. (TASE: ITMR) ("Itamar Medical" , a publicly-traded medical device company whose technology has been cleared by the U.S. Food and Drug Administration, or the FDA, for endothelial, or arterial, function assessment, which is a novel risk marker for cardiovascular disease.
GLMD: 4.10 (-0.05)
Respiratory Care Equipment and Supplies 2014-2020 - Global Strategic Business Report 2015
M2 - Thu Oct 15, 3:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qgh36t/respiratory_care) has announced the addition of the "Respiratory Care Equipment and Supplies - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, The Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. This report analyzes the worldwide markets for Respiratory Care Equipment and Supplies in US$ Thousand by the following Product Segments: Spirometers, Other Pulmonary Function Testing (PFT) Equipment, Sleep Apnea Diagnostic Devices, Ventilators, Humidifiers, Nebulizers, PAP (positive airway pressure) Devices, Oxygen Equipment, Manual Resuscitators, and Masks, Circuits & Disposables. The report profiles 158 companies including many key and niche players such as - Allied Healthcare Products, Inc. (USA) - Bio-Med Devices, Inc. (USA) - CareFusion Corp. (USA) - CAIRE, Inc. (USA) - Compumedics Ltd. (Australia) - Dr?ger Medical AG & Co. KGaA (Germany) - DeVilbiss Healthcare LLC (USA) - Fisher & Paykel Healthcare Corp. Limited (New Zealand) - GE Healthcare (UK) - Getinge Group (Sweden) - MAQUET GmbH & Co. KG (Germany) - Hamilton Medical AG (Switzerland) - Invacare Corporation (USA) - Itamar Medical Ltd. (Israel) - Medtronic PLC (Ireland) - nSpire Health, Inc. (USA) - PARI Medical Holding GmbH (Germany) - Philips Healthcare (The Netherlands) - ResMed (USA) - VORTRAN Medical Technology (USA) - Weinmann Ger?te f?r Medizin GmbH CCo. KG (Germany) Key Topics Covered: 1. Industry Overview 2. Competition In The Respiratory Care Market 3. Market Trends By Product Segment 4. Home Healthcare Market - A Broad Spectrum 5. Product Overview 6. Respiratory Therapy Equipment - A Review 7. Pap Devices - The Largest Market Segment In Respiratory Care 8. Ventilators For Respiratory Care 9. Review Of Select Disease Conditions Requiring Respiratory Care 10. Product Introductions, Innovations & Approvals 11. Recent Industry Activity 12. Focus On Select Global Players 13. Global Market Perspective Total Companies Profiled: 158 (including Divisions/Subsidiaries - 174) - The United States (84) - Canada (4) - Japan (9) - Europe (55) - - France (2) - - Germany (21) - - The United Kingdom (9) - - Italy (6) - - Spain (1) - - Rest of Europe (16) - Asia-Pacific (Excluding Japan) (16) - Latin America (1) - Middle East (5) For more information visit http://www.researchandmarkets.com/research/qg...atory_care
MDT: 82.94 (-0.05), IVC: 11.24 (+0.25), AHPI: 0.60 (-0.02)
Itamar Medical Offers a Total Sleep Apnea Management Solution to Cardiologists
PR Newswire - Wed May 13, 8:00AM CDT
For the first time, the company will manage and coordinate all stages of diagnosis and treatment for hospitals
European Sleep Apnea Devices Market, by Segment, and Sleep Apnea Therapeutic Devices - Forecast to 2019
M2 - Wed May 06, 6:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bjqw72/european_sleep) has announced the addition of the "European Sleep Apnea Devices Market, by Segment (Sleep Apnea Diagnostic Devices (Home Sleep Testing, Respiratory Polygraphs, Actigraphy Systems) and Sleep Apnea Therapeutic Devices (Pap Devices, Oxygen Devices, Airway Clearance Systems)-Forecast to 2019" report to their offering. The European sleep apnea devices market is projected to grow at a CAGR of 16.0% from 2014 to 2019 Germany holds the largest share of the European sleep apnea devices market. This large share of the German segment is attributed to the various driving forces, such as the increasing prevalence of sleep disorders in this region, increasing awareness level among patients and caregivers, rising number of cases of cardiovascular disorders, and the availability of technologically advanced diagnostic and therapeutic devices. However, the inadequate reimbursement coverage and patient compliance are perceived to hinder the growth of this market in the coming years. The high costs associated with the diagnosis and treatment of sleep apnea also restrains the growth of devices market in this region. The research report classifies the European sleep apnea devices market on the basis of segment into sleep apnea therapeutic devices and sleep apnea diagnostic devices. The sleep apnea therapeutic devices is further segmented based on types into home sleep testing/portable monitoring, sleep labs, respiratory polygraphs, two channel screening devices, single channel screening devices, and actigraphy systems. Similarly, the sleep apnea therapeutic devices market is segmented based on the types into Positive Airway Pressure (PAP) devices, masks, adaptive servo-ventilation, airway clearance systems, oxygen devices, and oral appliances. The PAP devices segment is the largest contributor in the therapeutic devices market. Moreover, the therapeutic devices segment is the largest contributor to the overall European sleep apnea devices market, having accounted for a share of 58.1% in 2014. Further, the European sleep apnea devices market is segmented based on the major countries of the region, such as Germany, France, the U.K., Italy, Spain, and the Rest of Europe (RoE). Germany is the largest market for sleep apnea devices in Europe. It accounted for a share of 27.9% of the European sleep apnea devices market in 2014. The major factors contributing to its dominance are the increasing prevalence of sleep disorders, rising awareness among patients and caregivers, and availability of advanced diagnosis and therapy options. France is the second-largest market in Europe and is projected to grow at a CAGR of 16.6% from 2014 to 2019. The U.K. houses the fastest-growing segment of the European sleep apnea devices market, and is projected to grow at the fastest CAGR from 2014 to 2019. The rising research & development activities pertaining to sleep disorders, rising obesity rates, and increasing awareness levels among patients and caregivers, are some of the factors expected to drive the growth of the European sleep apnea devices market in the coming years. Companies Mentioned - Ambulatory Monitoring, Inc. - BMC Medical Co., Ltd. - Carefusion Corporation - Compumedics Limited - Devilbiss Healthcare - Fisher and Paykel Healthcare Ltd. - Itamar Medical, Ltd. - Natus Medical, Inc. - Nihon Kohden - Nonin Medical - Philips Respironics (Subsidiary of Philips Healthcare Ltd.) - Resmed, Inc. - Somnomedics Gmbh - Weinmann Medical Devices Gmbh & Co. Kg For more information visit http://www.researchandmarkets.com/research/bj...pean_sleep
BABY: 34.16 (+0.19)
Sleep Apnea Devices Market by Segments (Sleep Apnea Therapeutic Devices, Sleep Apnea Diagnostic Devices) - Global Forecast to 2019
M2 - Thu Apr 23, 9:08AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lnxd5m/sleep_apnea) has announced the addition of the "Sleep Apnea Devices Market by Segments (Sleep Apnea Therapeutic Devices, Sleep Apnea Diagnostic Devices) - Global Forecast to 2019" report to their offering. The global sleep apnea devices market is expected to grow at a CAGR of 16.6% during the forecast period of 2014 to 2019. North America is the largest market in the global sleep apnea devices market, with a market share of 51.8% as of 2013, followed by Europe and Asia. The largest share of the North American segment is associated with various driving forces, such as the increasing patient pool of sleep apnea in this region, increasing awareness level among patients and caregivers, and the availability of technologically advanced diagnostic and therapeutic devices. It is estimated that approximately 4% of men and 2% of women suffer from Obstructive Sleep Apnea (OSA) globally. Also, the rising prevalence of comorbidities (such as drug-resistant hypertension, congestive heart failure, Type 2 diabetes, and stroke, among others) ensures that the global sleep apnea patient pool will grow in the coming years. However, the inadequate reimbursement coverage and patient compliance are perceived to hinder the growth of this market during the forecast period, 2014 to 2019. In this report, the global sleep apnea devices market is broadly classified on the basis of segments, namely sleep apnea therapeutic devices and sleep apnea diagnostic devices. The sleep apnea therapeutic devices is further segmented based on types, into home sleep testing/portable monitoring, sleep labs, respiratory polygraphs, two-channel screening devices, single channel screening devices, and actigraphy systems. Similarly, the sleep apnea therapeutic devices market is segmented based on types, into Positive Airway Pressure (PAP) devices, masks, adaptive servo-ventilation, airway clearance systems, oxygen devices, and oral appliances. PAP devices segment is the highest contributor in the therapeutic devices market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Global Sleep Apnea Devices Market, By Type 6 Global Sleep Apnea Market, By Geography 7 Global Sleep Apnea Devices Market: Competitive Landscape 8 Sleep Apnea Devices Market, By Company - Advanced Brain Monitoring,Inc., - Ambulatory Monitoring, Inc. - Bmc Medical Co., Ltd. - Cadwell Laboratories, Inc. - Carefusion Corporation - Clevemed - Compumedics Limited - Fisher And Paykel Healthcare Ltd. - Itamar Medical, Ltd. - Natus Medical, Inc. - Nihon Kohden - Nonin Medical - Novasom - Philips Respironics (Subsidiary Of Philips Healthcare Ltd.) - Resmed, Inc. - Weinmann Medical Devices Gmbh & Co. Kg For more information visit http://www.researchandmarkets.com/research/ln...leep_apnea
BABY: 34.16 (+0.19)
New Agreement Puts Itamar Medical Inc. and Arterial Health International on Track to Offer Greater Access to Innovative Cardiovascular Testing in the United States
PR Newswire - Mon Apr 20, 7:45AM CDT
Itamar Medical Inc., a subsidiary of Itamar Medical Ltd. (TASE: ITMR) and Arterial Health International LLC (AHI) announced today they have signed last month a representation agreement.
Micro Market Monitor: North American Sleep Apnea Devices
M2 - Thu Dec 18, 6:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/dnzfqg/micro_market) has announced the addition of the "Micro Market Monitor: North American Sleep Apnea Devices" report to their offering. The North American sleep apnea devices market is estimated to grow at a CAGR of 15.9% from 2014 to 2019. In 2013, the U.S. held the largest share in the North American sleep apnea devices market with 92.2%, followed by Canada. This market holds high growth potential in the future due to a number of forces favoring this market. These include the continuously growing base of sleep apnea patients, increasing awareness of sleep apnea and available diagnostic/therapeutic options, emerging popularity of oral appliances, and technological advancement. About 4% of men and 2% of women suffer from obstructive sleep apnea (OSA), globally. Due to rising obesity rates, the association of comorbidities such as drug-resistant hypertension, congestive heart failure, Type 2 diabetes, and stroke, the global sleep apnea patient pool is likely to grow in the years to come. However, dearth of reimbursement/insurance coverage and patient compliance seem to be hindering the growth of this market. In this report, the North American sleep apnea devices market is broadly classified into sleep apnea diagnostic devices and sleep apnea therapeutic devices. On the basis of products, the sleep apnea diagnostic devices market is further divided into home sleep testing/portable monitoring, traditional diagnostic (fixed PSG/in-lab PSG devices), respiratory polygraphs, two channel screening devices, single channel screening devices, and actigraphy systems. Key Topics Covered: 1 Executive Summary 2 Introduction 3 Market Overview 4 North American Sleep Apnea Devices Market, By Segment/Geography 5 Competitive Landscape 6 Company Profiles Companies Mentioned: - Advanced Brain Monitoring - Ambulatory Monitoring - Bmc Medical - Cadwell Laboratories - Carefusion Corporation - Clevemed - Compumedics - Fisher And Paykel Healthcare - Itamar Medical - Natus Medical - Nihon Kohden - Novasom - Philips Healthcare - Resmed - Weinmann Medical Devices Gmbh & Co For more information visit http://www.researchandmarkets.com/research/dn...cro_market
BABY: 34.16 (+0.19)
Sleep Apnea Diagnostic and Therapeutic Devices - 2014 Global Strategic Business Report
M2 - Thu Oct 30, 6:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qbnnd7/sleep_apnea) has announced the addition of the "Sleep Apnea Diagnostic and Therapeutic Devices - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 71 companies including many key and niche players such as: - Cadwell Laboratories, Inc. - CareFusion Corporation - Cleveland Medical Devices, Inc. - Compumedics Ltd. - DeVilbiss Healthcare - Global Medical Holdings LLC - Fisher & Paykel Healthcare Limited - GE Healthcare - Itamar Medical Ltd. - Invacare Corporation - Natus Medical Inc. - Embla Systems, Inc. - Grass Technologies - Philips Healthcare - ResMed Inc. - Teleflex Medical - Weinmann Ger?te f?r Medizin GmbH CCo. KG Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Market Overview 2. Market Trends And Dynamics 3. Sleep Apnea - A Synopsis 4. Sleep Apnea Diagnostic And Therapeutic Devices 5. Research Findings In Recent Past 6. Product Launches/Introductions 7. Recent Industry Activity 8. Focus On Select Players 9. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Middle East And Africa IV. Competitive Landscape Total Companies Profiled: 71 (including Divisions/Subsidiaries - 76) - The United States (48) - Canada (4) - Japan (1) - Europe (12) - - Germany (3) - - The United Kingdom (2) - - Italy (2) - - Spain (2) - - Rest of Europe (3) - Asia-Pacific (Excluding Japan) (
- Middle East (3) For more information visit http://www.researchandmarkets.com/research/qb...leep_apnea BABY: 34.16 (+0.19), IVC: 11.24 (+0.25), RMD: 59.54 (-0.01)
Respiratory Care Equipment and Supplies - 2014 Global Strategic Business Report
M2 - Tue Oct 28, 4:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9qjvss/respiratory_care) has announced the addition of the "Respiratory Care Equipment and Supplies - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. This report analyzes the worldwide markets for Respiratory Care Equipment and Supplies in US$ Thousands by the following Product Segments: - Spirometers - Other Pulmonary Function Testing (PFT) Equipment - Sleep Apnea Diagnostic Devices - Ventilators - Humidifiers - Nebulizers - PAP (positive airway pressure) - Devices - Oxygen Equipment - Manual Resuscitators - Masks - Circuits & Disposables The report profiles 148 companies including many key and niche players such as: - AirSep Corporation - Allied Healthcare Products, Inc. - CareFusion Corporation - Compumedics Limited - Covidien Ltd. - Dr?ger Medical AG & Co. KGaA - DeVilbiss Healthcare - Fisher & Paykel Healthcare Corporation Limited - GE Healthcare - Getinge Group - MAQUET GmbH & Co. KG - Hamilton Medical AG - Invacare Corporation - Itamar Medical Ltd. - nSpire Health, Inc. - Philips Healthcare - ResMed - VORTRAN Medical Technology - Weinmann Ger?te f?r Medizin GmbH CCo. KG Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Respiratory Care Industry Classification 3. Competition In The Respiratory Care Market 4. Market Trends And Growth Drivers By Segment 5. Respiratory Diagnostics Equipment - A Review 6. Respiratory Therapy Equipment - A Review 7. Review Of Select Disease Conditions Requiring Respiratory Care 8. Pap Devices - The Largest Market Segment In Respiratory Care 9. Home Healthcare Market - A Broad Spectrum 10. Ventilators For Respiratory Care 11. Product Introductions/Innovations 12. Recent Industry Activity 13. Focus On Select Global Players 14. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. The Middle East 7. Latin America IV. Competitive Landscape Total Companies Profiled: 148 (including Divisions/Subsidiaries - 174) - The United States (78) - Canada (4) - Japan (9) - Europe (62) - - France (4) - - Germany (24) - - The United Kingdom (9) - - Italy (7) - - Spain (2) - - Rest of Europe (16) - Asia-Pacific (Excluding Japan) (15) - Latin America (1) - Middle East (5) For more information visit http://www.researchandmarkets.com/research/9q...atory_care
IVC: 11.24 (+0.25), COV: 106.71 (-1.36), AHPI: 0.60 (-0.02)
Galmed Pharmaceuticals and Itamar Medical to Collaborate on Assessing Aramchol's Effect on Endothelial Function
PR Newswire - Mon Sep 29, 8:13AM CDT
Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed"
, a clinical-stage biopharmaceutical company focused on the development and commercialization of a once-daily, oral medication for the treatment of liver diseases and cholesterol gallstones, announced today that it purchased 60 EndoPAT(TM) devices and accessories from Itamar Medical Ltd. (TASE: ITMR) ("Itamar Medical" , a publicly-traded medical device company whose technology has been cleared by the U.S. Food and Drug Administration, or the FDA, for endothelial, or arterial, function assessment, which is a novel risk marker for cardiovascular disease. GLMD: 4.10 (-0.05)
